One of Kalorama's best-selling market research reports, this report provides the reader with a complete analysis of the domestic and international markets for pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatological Drugs is the sixth time Kalorama Information has comprehensively studied the dermatology markets.

Kalorama has completely re-evaluated the market from the ground up, and in addition to the usual primary research (interviews) of industry participants, clinicians, and regulators, we also conducted scores of interviews with users of Kalorama’s 2004 and 2006 dermatological studies to ensure that the current report contains the best possible data and the most useful analysis.

In this new edition, various shifts in the market are noted. There is information on bilogics, discussion of fillers and of treatments for skin infections such as MRSA. New companies have been added and consolidations in the industry have been addressed.

Market information is available for the years 2004 to 2011, with the focus year 2006 for competitive analysis. Overview and product descriptions of general therapy segments are covered, including prescription drugs to treat:

• Acne and Rosacea
• Antiaging and Photodamage
• Dermatitis and Seborrhea
• Fungal Infections
• Hair Loss and Hair Removal
• Hyperpigmentation/Melasma
• Psoriasis
• Skin Cancer, and
• Other Skin Disorders

Other data points include competitive market share, demographics, epidemiology, and geographic break down, which provide revenues for four regions:

• United States
• Europe
• Japan
• Rest of world

The study covers issues and trends affecting the market, research and developments, and more. In particular, the study explores the current and potential effects of the aging baby boomers on the prescription dermatology market and the continued demand for lifestyle drugs. Profiles of major market participants are included, including:

• Allergan Inc.
• Allergan Inamed Corporation
• Barrier Therapeutics, Inc
• Bayer AG
• Bradley Pharmaceuticals, Inc
• Bristol-Myers Squibb
• CollaGenex Pharmaceuticals
• Galderma S.A.
• Genentech, Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
• Medicis Pharmaceutical Corporation
• Merck & Company, Inc.
• Mylan Pharmaceuticals, Inc,
• Novartis Pharmaceuticals Corporation
• Nycomed Inc.
• Pfizer, Inc.
• Q-Med AB
• Roche Group (F. Hoffmann-La Roche Ltd.)
• Schering-Plough Corporation
• Sinclair Pharma Plc.
• SkinMedica
• Stiefel Laboratories, Inc.
• Valeant Pharmaceuticals, Inc.

Related Reports:

The Worldwide Market for In Vitro Diagnostic Tests, 8th Edition (pre-publication)
Jul 20, 2012 - KLI3811539 - $6,500.00

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
May 11, 2012 - KLI3889488 - $3,995.00

The Global Market for Medical Devices, 3rd. Edition
May 2, 2012 - KLI3873247 - $2,500.00

Out-of-Pocket Healthcare 2012
Apr 3, 2012 - KLI3824188 - $995.00

The World Anesthesia Drug Market (General, Local, Adjunctive)
Mar 22, 2012 - KLI3811533 - $3,995.00

EMR 2012: The Market for Electronic Medical Records
Mar 13, 2012 - KLI3804306 - $3,500.00

IVD Market Research Bundle (In Vitro Diagnostic Test Markets, BRIC and Other Regional Markets, Biomarker Testing and Other Pharmacodiagnostics)
Mar 3, 2012 - KLI2401913 - $5,995.00

World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
Mar 1, 2012 - KLI6801442 - $3,995.00

World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)
Feb 1, 2012 - KLI6772957 - $3,800.00

Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)
Jan 1, 2012 - KLI6490034 - $3,995.00